Assignee profile:

Herlev Hospital

City:

Herlev

Country:

Denmark

Published Applications:

12

Last publication date:

2022-10-27

Patent Grants:

9

Last grant date:

2023-06-06

Top Inventors for applications by Herlev Hospital

These are the the leading inventors for applications assigned to Herlev Hospital:

Recent patent applications by Herlev Hospital

Herlev Hospital based in Herlev, DK has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2022-10-27 ✅ Patent 11,668,705 granted on 2023-06-06
US20220341921A1
Physics

General detection and isolation of specific cells by binding of labeled molecules

#2 | 2022-06-30 ✅ Patent 11,402,373 granted on 2022-08-02
US20220205984A1
Physics

General detection and isolation of specific cells by binding of labeled molecules

#3 | 2018-06-28 ✅ Patent 11,585,806 granted on 2023-02-21
US20180180601A1
Physics

General detection and isolation of specific cells by binding of labeled molecules

#4 | 2017-08-24 ✅ Patent 10,736,950 granted on 2020-08-11
US20170239337A1
Human necessities

Vaccine compositions comprising tryptophan 2,3-dioxygenase or fragments thereof

#5 | 2015-03-05 ✅ Patent 9,943,599 granted on 2018-04-17
US20150065946A1
Human necessities

Therapeutic applications of calcium electroporation to effectively induce tumor necrosis

#6 | 2014-08-28 ✅ Patent 9,669,078 granted on 2017-06-06
US20140242101A1
Human necessities

PD-L1 based immunotherapy

#7 | 2014-04-17
US20140106985A1
Chemistry; metallurgy

MICRORNA BIOMARKERS FOR PROGNOSIS OF PATIENTS WITH PANCREATIC CANCER

#8 | 2013-11-21
US20130310276A1
Chemistry; metallurgy

MICRORNA FOR DIAGNOSIS OF PANCREATIC CANCER

#9 | 2013-11-07
US20130296995A1
Human necessities

Method For Treating A Tissue Region With An Electric Field

#10 | 2012-03-22 ✅ Patent 8,580,520 granted on 2013-11-12
US20120070853A1
Physics

YKL-40 as a marker for gastrointestinal cancers

#11 | 2011-12-29 ✅ Patent 9,433,666 granted on 2016-09-06
US20110318372A1
Human necessities

Indoleamine 2,3-dioxygenase based immunotherapy

#12 | 2011-02-24 ✅ Patent 8,697,384 granted on 2014-04-15
US20110045518A1
Physics

YKL-40 as a general marker for non-specific disease

Also check out Herlev Hospital's (Herlev, Denmark) applicant profile with 7 patent applications submitted.

AssigneeID:

44825 ⎘